VLS GLP-1 5mg Pen
VLS GLP-1 5mg Pen
In short 产品简述
VLS GLP-1 5mg Prefilled Pen
is a pharmaceutical-grade GLP-1 receptor agonist in a convenient ready-to-use injection pen. This VLS GLP-1 formulation delivers adjustable doses for flexible research protocols with included disposable needles. No mixing required – simply dial your dose and administer.
Specifications 规格参数
About the Product 产品详情
💉 Prefilled Pen – Ready To Use
This
VLS GLP-1
pen comes
and ready for subcutaneous administration. Adjustable dosing for flexible research protocols. Includes disposable needles – no reconstitution required.
VLS GLP-1 5mg Prefilled Pen
is a pharmaceutical-grade
GLP-1 receptor agonist
in a convenient ready-to-use injection pen. This
VLS GLP-1
formulation offers researchers a high-purity compound for advanced studies in glycemic control, appetite regulation, and metabolic health. The extended half-life of approximately 7 days makes it ideal for weekly administration protocols. Available for
UK delivery
with fast dispatch.
VLS GLP-1 Pen Specifications
Peptide
GLP-1
Type
GLP-1 Agonist
Total Content
Half-Life
~7 days
Form
Prefilled Pen
Includes
4 Needles
VLS
GLP-1 5mg Prefilled Pen
VLS Pharmaceuticals
VLS GLP-1 Research Benefits
GLP-1 receptor activation
Appetite regulation
Delayed gastric emptying
Extended half-life
Convenient dosing
How VLS GLP-1 Works
GLP-1 analog
is a
GLP-1 receptor agonist
that mimics the action of glucagon-like peptide-1, a naturally occurring incretin hormone. It enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon levels, and slows gastric emptying.
VLS Pharmaceuticals
produces this compound to exacting pharmaceutical standards.
Research indicates
VLS GLP-1
works through multiple mechanisms including direct effects on pancreatic beta cells, modulation of appetite centres in the hypothalamus, and delayed gastric emptying. The extended half-life of approximately 7 days enables once-weekly dosing, making it particularly convenient for sustained research protocols.
💉 PEN DOSING INFORMATION
Total content:
5mg GLP-1 per pen.
Typical research protocol:
Once-weekly subcutaneous administration. Protocols often start at lower doses and titrate upwards.
Adjustable dosing:
Dial to desired dose per injection as required for research protocol.
Included:
4 single-use disposable needles per box.
VLS GLP-1 vs Tirzepatide
While
VLS GLP-1
targets only the GLP-1 receptor, Tirzepatide activates both GLP-1 and GIP receptors for a dual-action approach. GLP-1 has extensive research supporting its efficacy in glycemic control and weight management. Many researchers compare both
VLS
compounds to understand the relative contributions of single versus dual receptor activation in metabolic studies.
Why Choose VLS GLP-1?
VLS Pharmaceuticals
is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. The
VLS GLP-1
prefilled pen offers unmatched convenience – no reconstitution required, no syringes, just precise adjustable doses in a ready-to-use format. Every
VLS
product undergoes rigorous quality control to ensure researchers receive reliable compounds for their studies.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
Legal Notice:
This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.
What's in the Box 包装清单
- 1 × 预充注射笔
- 配套密封笔尖（数量以供应商包装为准）
Usage 使用说明
- 每次使用更换全新密封笔尖
- 旋拧刻度并核对剂量窗口
- 按研究方案设定的剂量给药
Handling & Storage 储存条件
- 2-8°C 冷藏，勿冷冻
- 避光保存于原包装盒内
- 首次启用后按供应商建议的期限内使用
Applications 应用方向
For research purposes only 免责声明
本条目信息整理自公开销售页面（The Ped Shop），仅供研究与信息参考。所列产品按研究用途展示，不作为药品或保健品销售，不用于诊断、治疗、治愈或预防任何疾病。实际规格、价格与库存以供应商页面为准。
💉 Prefilled Pen – Ready To Use
This
VLS GLP-1
pen comes
and ready for subcutaneous administration. Adjustable dosing for flexible research protocols. Includes disposable needles – no reconstitution required.
VLS GLP-1 5mg Prefilled Pen
is a pharmaceutical-grade
GLP-1 receptor agonist
in a convenient ready-to-use injection pen. This
VLS GLP-1
formulation offers researchers a high-purity compound for advanced studies in glycemic control, appetite regulation, and metabolic health. The extended half-life of approximately 7 days makes it ideal for weekly administration protocols. Available for
UK delivery
with fast dispatch.
VLS GLP-1 Pen Specifications
Peptide
GLP-1
Type
GLP-1 Agonist
Total Content
Half-Life
~7 days
Form
Prefilled Pen
Includes
4 Needles
VLS
GLP-1 5mg Prefilled Pen
VLS Pharmaceuticals
VLS GLP-1 Research Benefits
GLP-1 receptor activation
Appetite regulation
Delayed gastric emptying
Extended half-life
Convenient dosing
How VLS GLP-1 Works
GLP-1 analog
is a
GLP-1 receptor agonist
that mimics the action of glucagon-like peptide-1, a naturally occurring incretin hormone. It enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon levels, and slows gastric emptying.
VLS Pharmaceuticals
produces this compound to exacting pharmaceutical standards.
Research indicates
VLS GLP-1
works through multiple mechanisms including direct effects on pancreatic beta cells, modulation of appetite centres in the hypothalamus, and delayed gastric emptying. The extended half-life of approximately 7 days enables once-weekly dosing, making it particularly convenient for sustained research protocols.
💉 PEN DOSING INFORMATION
Total content:
5mg GLP-1 per pen.
Typical research protocol:
Once-weekly subcutaneous administration. Protocols often start at lower doses and titrate upwards.
Adjustable dosing:
Dial to desired dose per injection as required for research protocol.
Included:
4 single-use disposable needles per box.
VLS GLP-1 vs Tirzepatide
While
VLS GLP-1
targets only the GLP-1 receptor, Tirzepatide activates both GLP-1 and GIP receptors for a dual-action approach. GLP-1 has extensive research supporting its efficacy in glycemic control and weight management. Many researchers compare both
VLS
compounds to understand the relative contributions of single versus dual receptor activation in metabolic studies.
Why Choose VLS GLP-1?
VLS Pharmaceuticals
is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. The
VLS GLP-1
prefilled pen offers unmatched convenience – no reconstitution required, no syringes, just precise adjustable doses in a ready-to-use format. Every
VLS
product undergoes rigorous quality control to ensure researchers receive reliable compounds for their studies.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
Legal Notice:
This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.